Oncolytics Biotech financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M C$0.00M
GM % Gross Margin %
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
OM Operating Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Earnings Per Share
C$-3.71 C$-3.99 C$-3.14 C$-3.04 C$-3.80 C$-4.56 C$-2.66 C$-2.00 C$-1.14 C$-1.24 C$-1.14 C$-1.06 C$-0.93 C$-0.64 C$-0.49 C$-0.43 C$-0.49 C$0.00
Div. Dividends
C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00 C$0.00
PR % Payout Ratio %
0 0 0 0 0 0 -0.00% 0 -0.00% -0.00% -0.00% 0 0 0 0 0 0 0 0 0 0
Sha. Shares
3.12m 3.48m 3.83m 4.33m 4.61m 6.48m 7.14m 7.5m 8.07m 8.92m 9.52m 12.44m 12.76m 14.92m 16.97m 26.36m 43.32m 55.03m 55.03m 0m 75.4m
OCF Operating Cash Flow
C$-9.22M C$-11.05M C$-13.00M C$-14.42M C$-15.29M C$-16.06M C$-17.88M C$-22.54M C$-34.26M C$-24.44M C$-19.68M C$-15.03M C$-12.48M C$-14.89M C$-11.92M C$-19.91M C$-22.07M C$-22.43M C$-23.36M C$-28.45M C$0.00M
FCF Free Cash Flow
C$-9.24M C$-11.11M C$-13.04M C$-14.51M C$-15.40M C$-16.07M C$-17.96M C$-22.80M C$-34.39M C$-24.69M C$-19.83M C$-15.14M C$-12.50M C$-15.00M C$-12.03M C$-19.92M C$-22.10M C$-22.72M C$-23.41M C$-33.20M C$0.00M
FCFS Free Cash Flow Per Share
C$-3.34 C$-3.52 C$-3.41 C$-3.41 C$-3.54 C$-3.09 C$-2.73 C$-3.05 C$-4.29 C$-2.81 C$-2.14 C$-1.28 C$-0.99 C$-1.08 C$-0.75 C$-0.90 C$-0.55 C$-0.42 C$-0.40 C$-0.42 C$0.00